TPM1, His, Human
Tropomyosin-1 (TPM1), a widely expressed actin-binding protein, is downregulated in many tumors and associated with cancer progression. TPM1 overexpression in RCC cell lines can induce tumor cell apoptosis via the p53-mediated mitochondrial pathway. Further studies are needed to fully elucidate the potential of TPM1 as a candidate for RCC targeted therapy in the future.
| ¥3300 在线订购包邮(港澳台除外) | |
| Z05909-100 | |
|
|
|
|
|
|
|
|
|
| 咨询产品问题 | |